References
Faitelson Y, Grunebaum E. Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders. Clin Immunol. 2014;155:118–25.
Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev. 2015;26(3):263–80.
Ramirez-Alejo N, Blancas-Galicia L, Yamazaki-Nakashimada M, et al. Molecular analysis for patients with IL-12 receptor β1 deficiency. Clin Genet. 2014;86:161–6.
Sepulveda FE, Maschalidi S, Vosshenrich CA, et al. A novel immunoregulatory role for NK cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood. 2015;125:1427–34.
Tesi B, Sieni E, Neves C, et al. Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFN-γ receptor deficiency. J Allergy Clin Immunol. 2015. doi:10.1016/j.jaci.2014.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muriel-Vizcaino, R., Yamazaki-Nakashimada, M., López-Herrera, G. et al. Hemophagocytic Lymphohistiocytosis as a Complication in Patients with MSMD. J Clin Immunol 36, 420–422 (2016). https://doi.org/10.1007/s10875-016-0292-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-016-0292-3